...
首页> 外文期刊>Drug development and industrial pharmacy >Formulation optimization and pharmacokinetics evaluation of oral self-microemulsifying drug delivery system for poorly water soluble drug cinacalcet and no food effect
【24h】

Formulation optimization and pharmacokinetics evaluation of oral self-microemulsifying drug delivery system for poorly water soluble drug cinacalcet and no food effect

机译:适用于水溶性药物诱变药物诱饵药物递送系统的配方优化和药代动力学评价,无食物效应

获取原文
获取原文并翻译 | 示例
           

摘要

The present research indicated that a new self-microemulsifying drug delivery systems (SMEDDS) were used to reduce the food effect of poorly water-soluble drug cinacalcet and enhance the bioavailability in beagle dogs by oral gavage. Ethyl oleate, OP-10, and PEG-200 was selected as the oil phase, surfactant and co-surfactant of cinacalcet-SMEDDS by the solubility and phase diagram studies. Central Composite Design-Response Surface Methodology was used to determine the ratio of surfactant and co-surfactant, the amount of oil for optimizing the SMEDDS formation. The prepared formulations were further characterized by the droplet size, self-microemulsifying time, zeta potential, polydispersity index (PDI), and robustness to dilution. The in vitro release profile of cinacalcet-SMEDDS was determined in four different release medium and in fasted state and fed state of simulated gastrointestinal fluid. Cinaclcet-SMEDDS were implemented under fed and fasted state in dogs and product REGPARA (R) was used as a comparison to the prepared formulation in the pharmacokinetics. The result showed the components of SMEDDS, the amount of oil, the ratio of surfactant, and co-surfactant was optimized using solubility, pseudo-ternary phase diagram studies, and response surface methodology. In vitro drug release studies indicated that the cinacalcet-SMEDDS eliminated the effect of pH variability in release medium and variational gastroenteric environments with improved drug release performance. Pharmacokinetic studies revealed that the profiles of cinacalcet-SMEDDS were similar both in the fasted and fed state compared with commercial product, indicating the formulation significantly promoted the absorption, enhanced bioavailability and had no food effect essentially. It is concluded that poorly water-soluble drug cinacalcet was improved in the solubility and bioavailability by using a successful oral dosage form the SMEDDS, and eliminated food effect as well.
机译:本研究表明,新的自我微乳化药物递送系统(SMEDDS)用于减少水溶性药物诱饵的食物效果,并通过口服饲养增强比格犬的生物利用度。通过溶解度和相图研究选择乙酯,OP-10和PEG-200作为Cinacalcet-Smedds的油相,表面活性剂和共表面活性剂。中央复合设计 - 响应表面方法用于确定表面活性剂和共表面活性剂的比例,用于优化SMEDDS形成的油量。通过液滴尺寸,自微乳液时间,Zeta电位,多分散性指数(PDI)和稀释性的鲁棒性,进一步表征了制备的制剂。在四种不同的释放介质和禁食状态和模拟胃肠流体的禁食状态下测定Cinacalcet-Smedds的体外释放曲线。 CinaClcet-Smedds在喂养和捕获的禁食状态下实施,并将产品RegPara用于与药代动力学的制备的制剂的比较。结果表明,使用溶解度,伪三元相图研究和响应表面方法优化了SMEDDS的组分,油的量,表面活性剂的比例和共表面活性剂。体外药物释放研究表明,Cinacalcet-Smedds消除了释放培养基和变分气体环境中pH变异性的影响,具有改善的药物释放性能。药代动力学研究表明,与商业产品相比,Cinacalcet-Smedds的曲线在禁食和喂养状态下都是相似的,表明制剂显着促进了吸收,增强的生物利用度,并没有粮食效果。结论是,通过使用成功的口服剂量形成SMEDDS的溶解性和生物利用度,溶解性和生物利用度较差,并消除了食物效果,并消除了食物效果的溶解性和生物利用度较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号